FeLV or FIV infected cats treated with recombinant human interferon-α improved in terms of most of the parameters analyzed (clinical status, anemia, white cell counts and CD4+/CD8+ ratio) in another study [24], similar to that described previously in FeIFN-ω. This evidence concerns the gene CD8A and anemia (phenotype).